← All investors
Pontifax
12 portfolio companies · 2 on the map · $909.1M raised · 2 cities
Portfolio map
2 Pontifax portfolio companies on the map.
Portfolio companies

UroGen Pharma
Princeton
UroGen Pharma is a clinical-stage biopharmaceutical company focused on developing novel therapies.
Biotechnology Research$529.6MEst. 2004
Keros Therapeutics
Lexington
Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.
Biotechnology Research$379.5MEst. 2016
More portfolio companies
10 more Pontifax investments we track beyond the map.
AnaveonBottmingen · Series B
Step PharmaParis · Series C
Amolyt PharmaÉcully · Series C
Vanqua BioChicago · Series B
Indapta TherapeuticsSan Francisco · Venture
Neogene TherapeuticsAmsterdam · Series A
Theseus PharmaceuticalsNew York · Series B
89bioSan Francisco · Series A
TargEDysSaulx-les-chartreux · Series A
Arno TherapeuticsParsippany · Post-IPO Equity
Portfolio map
2 Pontifax portfolio companies on the map.